Cristian Luput, Director at MAIA Biotechnology, Inc. (MAIA), bought 24 shares at $4.25 ($102) on 2023-02-15, disclosed to the SEC on 2023-02-16.
Scheduled purchase ($102) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.25 | 14 | $60 | 58.3% |
| 2 | $4.25 | 10 | $43 | 41.7% |
| Total | $4.25 avg | 24 | $102 | 100% |
| Filing → |
| MAIA | BUY | 2024-11-04 | $111K | — | Filing → |
| MAIA | BUY | 2024-03-15 | $162K | — | Filing → |
| MAIA | BUY | 2023-05-17 | $8K | — | Filing → |